Cogent Biosciences, Inc. (COGT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within…
Source: Yahoo Finance
Sector & Industry
Cogent Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Cogent Biosciences, Inc. at a Glance
| Company | Cogent Biosciences, Inc. |
| Ticker | COGT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $34.76 |
| Market cap | $6.03B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.16 |
| 52-week high | $43.73 |
| 52-week low | $11.60 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.31 |
| Return on equity (ROE) | -109.74% |
| Debt-to-equity | 45.88% |
| Average volume | 2.30M |
| Shares outstanding | 173.52M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 258 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Cogent Biosciences, Inc.'s current P/E ratio?
- Cogent Biosciences, Inc. (COGT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Cogent Biosciences, Inc.'s market capitalisation?
- Cogent Biosciences, Inc.'s market cap is $6.03B based on our latest snapshot. See how it ranks by market cap →
- What is COGT's 52-week range?
- Over the past 52 weeks, COGT has traded between $11.60 and $43.73. What does the 52-week range mean? →
- How volatile is Cogent Biosciences, Inc. compared to the market?
- Cogent Biosciences, Inc. has a beta of 0.31, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Cogent Biosciences, Inc. pay a dividend?
- Cogent Biosciences, Inc. does not currently pay a dividend according to our latest data.
- What exchange is COGT listed on?
- COGT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Cogent Biosciences, Inc. in?
- Cogent Biosciences, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →